Skip to main content

Elite Health Systems Inc.

Data quality: 100%
EHSI
OTC Services Health Services
$1.26
$0.00 (0.00%)
Mkt Cap: 27.64 M
Price
$1.26
Mkt Cap
27.64 M
Day Range
$1.26 — $1.26
52-Week Range
$0.69 — $1.50
Volume
1,340
Open $1.26
50D / 200D Avg
$1.29
2.63% below
50D / 200D Avg
$1.31
3.85% below

Quick Summary

Key Takeaways

Negative free cash flow of -1.98 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-69.19%
Below sector avg (-15.74%)
ROIC-45.13%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio15.83
Interest CoverageN/A

Valuation

PE (TTM)
-9.07
Below sector avg (-1.17)
P/B Ratio5.51
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -9.1 -1.2
P/B 5.5 1.4
ROE % -69.2 -15.7
Net Margin % -18.3
Rev Growth 5Y % 4.2
D/E 0.4

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -3.05 M
ROE -69.19% ROA -65.56%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -1.98 M
ROIC -45.13% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 15.83
Interest Coverage N/A Asset Turnover 0.00
Working Capital 4.00 M Tangible Book Value 5.02 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9.07 Forward P/E N/A
P/B Ratio 5.51 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -7.14%
Market Cap 27.64 M Enterprise Value 23.67 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.00
FCF / Share -0.09 OCF / Share -0.09
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 64.82%
SBC-Adj. FCF -2.48 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0.0 0.0 0.0 1.06 M 3.17 M
Net Income -2.06 M -816,000.0 -1.34 M -627,000.0 533,000.0
EPS (Diluted) -0.17 -0.17 -0.08
Gross Profit
Operating Income -1.79 M -765,000.0 -1.39 M -89,000.0 1.62 M
EBITDA
R&D Expenses
SG&A Expenses 1.79 M 765,000.0 1.39 M 1.06 M 1.20 M
D&A
Interest Expense 2,000.0 0.0 3,000.0 25,000.0
Income Tax -163,000.0 0.0 39,000.0 120,000.0 323,000.0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 4.32 M 1.32 M 1.75 M 3.69 M 4.17 M
Total Liabilities 143,000.0 676,000.0 291,000.0 361,000.0 487,000.0
Shareholders' Equity 4.18 M 645,000.0 1.24 M 2.83 M 3.69 M
Total Debt
Cash & Equivalents 4.03 M 466,000.0 1.54 M 2.18 M 2.03 M
Current Assets 4.25 M 527,000.0 1.56 M 2.24 M 3.01 M
Current Liabilities 94,000.0 607,000.0 280,000.0 327,000.0 410,000.0